The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...

LONDON, April 24 (Reuters) - Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk (NOVOb.CO), opens new tab has raised its annual sales guidance several times a year.

Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...

A daily pill appears to lower blood sugar in people with type 2 diabetes as effectively as injectable drugs like Ozempic and Mounjaro. The medication, called orforglipron, also led to substantial ...

The use of weight loss treatments like Ozempic and Wegovy has skyrocketed in the Western world. But as more people turn to these treatments, which mimic the appetite-suppressing hormone GLP-1 ...

You’ll need to attach a new needle to the pen each time you take a dose. With Wegovy, each pen comes with a needle already attached. Each pen contains a single dose. You’ll use a new pen for ...

Wegovy injection pens come with a needle attached. Each pen is for single use only. It delivers one dose of medication. You’ll use a new pen each time you take a dose. You (or a caregiver ...

In January, they were overtaken by Novartis’ Pluvicto and Johnson & Johnson’s Tremfya; last month, it was Novo Nordisk’s Wegovy and J&J’s immunology med that leapfrogged over the previous ...

“Bagizza now, Wegovy later,” reads the ad outside the soon-to-open restaurant. “This is basically like advertising cigarettes and then underneath it being like ‘then a lung transplant for you.

LONDON (Reuters) -Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several times a year. But recent weak U.S. prescription data is ...

The FDA expanded the approval of osilodrostat (Isturisa) to include treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or was not ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid. By Margot Sanger ...